Cargando…
Oncostatin M induces association of Grb2 with Janus kinase JAK2 in multiple myeloma cells
Oncostatin M (OSM) is a 28-kD glycoprotein recently identified as a growth factor for human multiple myeloma cells. It belongs to a family of distantly related cytokines that includes interleukin 6, ciliary neurotrophic factor, leukemia-inhibitory factor, and interleukin 11. These cytokines initiate...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192257/ https://www.ncbi.nlm.nih.gov/pubmed/7500025 |
Ejemplares similares
-
The Janus kinases (Jaks)
por: Yamaoka, Kunihiro, et al.
Publicado: (2004) -
The Janus Kinase (JAK) FERM and SH2 Domains: Bringing Specificity to JAK–Receptor Interactions
por: Ferrao, Ryan, et al.
Publicado: (2017) -
CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes
por: Migita, Kiyoshi, et al.
Publicado: (2011) -
Expression of nephronectin is inhibited by oncostatin M via both JAK/STAT and MAPK pathways
por: Kurosawa, Tamaki, et al.
Publicado: (2015) -
Oncostatin M receptor β deficiency attenuates atherogenesis by inhibiting JAK2/STAT3 signaling in macrophages
por: Zhang, Xin, et al.
Publicado: (2017)